| Catalog Number |
07026889190 |
| Medical Device Problem Codes |
False Positive Result (1227); High Test Results (2457)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
10/17/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
The initial reporter stated they received discrepant results for one patient sample tested with elecsys anti-hcv ii on a cobas e 801 analytical unit.The customer stated that the patient sample initially resulted in an anti-hcv value of 3 coi (reactive) and it repeated as 3 coi (reactive).Specific raw data was provided for an anti-hcv value of 3.4 coi (reactive).The sample was repeated using the abbott anti-hcv method on (b)(6) 2025, resulting in a value of 0.11 s/co (non-reactive).
|
| |
|
Additional Manufacturer Narrative
|
|
The serial number of the e 801 analyzer is (b)(6).Calibration data from (b)(6) 2025 was within expected ranges.The investigation is ongoing.
|
| |
|
Additional Manufacturer Narrative
|
|
Calibration data provided from after the event was within expected ranges.Quality controls were within expected ranges.A review of alarm trace data showed no relevant alarms.Instrument checks were acceptable.False reactive results may occur in elecsys anti-hcv ii, as the labeled assay specificity is < 100%.All initially reactive or borderline samples should be retested in duplicate using the elecsys anti-hcv ii assay.Confirmation is via supplemental methods.If one or both measurements remain borderline the analysis of a follow-up sample is recommended.Or diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings.The elecsys anti-hcv ii assay performs within specification.
|
| |
|
Search Alerts/Recalls
|